Remove companies bayer-ag
article thumbnail

Cipla Files Fresh Bid To Revoke Bayer's Xarelto Patent

IP Law 360

An Indian pharmaceutical company has asked a London court to invalidate a Bayer Global AG patent that protects the blockbuster blood-thinner Xarelto, marking the latest attempt to nix the patent protecting the key ingredient of the drug.

Patent 40
article thumbnail

'Flanax' Trademark Fight Heading To High Court Again

IP Law 360

An American company that has been battling for more than a decade with German drugmaker Bayer AG over the trademark "Flanax" — Bayer's Mexican brand name for Aleve — is now once again asking the U.S. Supreme Court to tackle the case.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Case Analysis of NATCO v. Bayer

IP and Legal Filings

The present case deals with the compulsory license awarded to a domestic generic pharmaceutical private company, Natco, for the manufacture and sale of the kidney cancer drug Nexavar, patented by Bayer Corporation in India. This notion is also evident from cases like Novartis AG v. Bayer first appeared on IPLF.

article thumbnail

Trademarks, Territoriality, and Migration

Patently-O

Coca-Cola Company , 21-2209 (Fed. Although goods are often shipped globally, many companies manufacture and sell region-specific products. That divide allows the company to cater to local market preferences and regulations and also avoid potential arbitrage. Bayer Consumer Care AG , 819 F.3d ” = = =.

Trademark 119
article thumbnail

Patent Law at the Supreme Court October 2021

Patently-O

Chevron Oronite Company LLC , No. Sulzer Mixpac AG v. Bayer Consumer Care AG , No. Janssen Pharmaceutica, N.V. , 21-202 ( NHK-Fintiv rule for denying petitions; appealability of IPR petition denial); Apple Inc. Optis Cellular Technology, LLC , No. 21-118 (mandamus review of IPR petition denial); Infineum USA L.P.

article thumbnail

USC IP year in review, TM/ROP

43(B)log

Similarly, Sulzer Mixpac AG v. The Bayer v. Belmora case; the Fourth Circuit allowed Bayer to seek the complete elimination of Belmora’s ability to use the challenged mark, though Belmora has sought cert on this question. A&N Trading Co., 19-2951 (2d Cir. Punchbowl sued AJ for trademark infringement and related claims.

IP 94